anti-Cytokeratin-5 / -6 (human), Rabbit Monoclonal (RM341)

RevMAb Biosciences

anti-Cytokeratin-5 / -6 (human), Rabbit Monoclonal (RM341)

10

Western Blot, ImmunoHistoChemistry

Research Use Only

Monoclonal

RM341

KRT5

keratin 5

58 kda cytokeratin; CK5; CK-5; cytokeratin-5; DDD; DDD1; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; K5; keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin, type II cytoskeletal 5; KRT5A; type-II keratin Kb5

Rabbit

IgG

Keratin, type II cytoskeletal 5

Cytokeratins are keratin proteins found in the intracytoplasmic cytoskeleton of epithelial tissue (at least 20 different polypeptides). They are an important component of intermediate filaments, which help cells resist mechanical stress. Expression of these cytokeratins within epithelial cells is largely specific to particular organs or tissues. The subsets of cytokeratins which an epithelial cell expresses depends mainly on the type of epithelium, the moment in the course of terminal differentiation and the stage of development. Thus a specific cytokeratin expression profile allows the identification of epithelial cells. Furthermore, this applies also to the malignant counterparts of the epithelia, (carcinomas). Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. Cytokeratin-5/-6 are type II cytokeratins specifically expressed in the basal layer of the epidermis. Targeting both cytokeratin 5 and cytokeratin 6 is used in immunohistochemistry. This often called CK5/6 staining is used for identifying basal cells or myoepithelial cells in the breast and prostate, for breast pathology in distinguishing usual ductal hyperplasia (UDH) and papillary lesions from ductal carcinoma in situ, to distinguish between the diagnosis of papilloma or papillary carcinoma, and in the lung, distinguishing epithelioid mesothelioma (CK5/6 positive in 83%) from lung adenocarcinoma (CK5/6 negative in 85%). - Recombinant Antibody. This antibody reacts to both human CK-5 (Cytokeratin 5) and CK-6 (Cytokeratin 6). Applications: WB, IHC. Source: Rabbit. Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. Cytokeratins are keratin proteins found in the intracytoplasmic cytoskeleton of epithelial tissue (at least 20 different polypeptides). They are an important component of intermediate filaments, which help cells resist mechanical stress. Expression of these cytokeratins within epithelial cells is largely specific to particular organs or tissues. The subsets of cytokeratins which an epithelial cell expresses depends mainly on the type of epithelium, the moment in the course of terminal differentiation and the stage of development. Thus a specific cytokeratin expression profile allows the identification of epithelial cells. Furthermore, this applies also to the malignant counterparts of the epithelia, (carcinomas). Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. Cytokeratin-5/-6 are type II cytokeratins specifically expressed in the basal layer of the epidermis. Targeting both cytokeratin 5 and cytokeratin 6 is used in immunohistochemistry. This often called CK5/6 staining is used for identifying basal cells or myoepithelial cells in the breast and prostate, for breast pathology in distinguishing usual ductal hyperplasia (UDH) and papillary lesions from ductal carcinoma in situ, to distinguish between the diagnosis of papilloma or papillary carcinoma, and in the lung, distinguishing epithelioid mesothelioma (CK5/6 positive in 83%) from lung adenocarcinoma (CK5/6 negative in 85%).

-20°C

12352203